Cancer Powered by Trendolizer

Promising cancer drug aces human clinical trials

Trending story found on newatlas.com
Promising cancer drug aces human clinical trials
A new cancer drug known as BLU-667 has moved through phase I human trials, and the results are promising. Taken orally, the drug targets what are known as RET-driven cancers, including types of thyroid and lung cancers, which are normally hard to treat.
[Source: newatlas.com] [ Comments ] [See why this is trending]

Trend graph:

Comments